Levocetirizine Dihydrochloride 5 mg + Montelukast Sodium 10 mg
Brand Name
L-CET MX Tablets
Manufacturer
Voizmed Pharma Pvt Ltd
Dosage Form
tablet
Strength
15mg
Levocetirizine Dihydrochloride IP 5 mg Montelukast Sodium IP eq. to Montelukast 10 mg Excipients q.s.
L-CET MX Tablets is a high-quality tablet developed by Voizmed Pharma Pvt Ltd. Each formulation contains Levocetirizine Dihydrochloride IP 5 mg Montelukast Sodium IP eq. to Montelukast 10 mg Excipients q.s. , providing an effective therapeutic action for patients in need of reliable treatment under the antiviral category.
This medicine is available in a strength of 15mg and is produced in India. It is typically prescribed as a prescription drug and falls under Schedule non-scheduled classification according to pharmaceutical standards.
L-CET MX Tablets is also marketed under the brand name L-CET MX Tablets, ensuring trusted quality and proven results. Its unique composition and formulation make it suitable for patients seeking consistent and safe outcomes.
Belonging to the biotech drug type, this product is used in the management of various health conditions associated with the antiviral group. Regular use should be as directed by a healthcare professional to achieve the best results.
Company Name
Sanarex Pharma Pvt Ltd
City
Patna
State
Bihar
Company
Voizmed Pharma Pvt Ltd
Country of Origin
India
| Product Name | L-CET MX TABLETS |
| Generic Name | LEVOCETIRIZINE DIHYDROCHLORIDE 5 MG + MONTELUKAST SODIUM 10 MG |
| Brand Name | L-CET MX TABLETS |
| Dosage Form | TABLET |
| Strength | 15MG |
| Manufacturer | VOIZMED PHARMA PVT LTD |
| Country of Origin | INDIA |
| Therapeutic Category | ANTIVIRAL |
| Prescription Type | PRESCRIPTION |
| Schedule | NON-SCHEDULED |
| Drug Type | BIOTECH |